Upload

Loading...

This video is unavailable.

Sorry about that.

Watch Queue

TV Queue

Watch QueueTV Queue

    Loading...

Watch Queue
TV Queue
__count__/__total__
  1. 122

    Periodic fever syndromes

  2. 123

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  3. 124

    A lifelong challenge: periodic fever syndromes

  4. 125

    Connections

  5. 126

    Each Voice Counts - The Women: Part 1

  6. 127

    Each Voice Counts - The Women: Part 2

  7. 128

    Unanswered questions about living with advanced breast cancer

  8. 129

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  9. 130

    Novartis International Biotechnology Leadership Camp 2012

  10. 131

    Journey of Chronic Myeloid Leukemia (CML)

  11. 132

    A look at the past decade in GIST: Chapter 6

  12. 133

    A look at the past decade in GIST: Chapter 5

  13. 134

    A look at the past decade in GIST: Chapter 4

  14. 135

    Vision loss due to Retinal Vein Occlusion (RVO)

  15. 136

    Vision loss due to Diabetic Macular Edema (DME)

  16. 137

    Vision loss due to wet age-related macular degeneration (wet AMD)

  17. 138

    A look at the past decade in GIST: Chapter 3

  18. 139

    Building the next generation of scientists

  19. 140

    A look at the past decade in GIST: Chapter 2

  20. 141

    A look at the past decade in GIST: Chapter 1

  21. 142

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  22. 143

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  23. 144

    Advanced breast cancer 101

  24. 145

    The mTOR pathway in ER+ advanced breast cancer

  25. 146

    Life in a Circle

  26. 147

    Understanding advanced breast cancer

  27. 148

    A Gift for Living

  28. 149

    The Villages Miles Away

  29. 150

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  30. 151

    Could your dog or cat be suffering from an allergy?

  31. 152

    Innovating to help eliminate malaria

  32. 153

    Malaria milestone video message

  33. 154

    Leo and Kya, friends against malaria

  34. 155

    The need for progress: what if?

  35. 156

    The myelofibrosis educational journey

  36. 157

    Understanding the progression of myelofibrosis

  37. 158

    Understanding the management of myelofibrosis

  38. 159

    The myelofibrosis disease burden

  39. 160

    The disease pathway associated with myelofibrosis

  40. 161

    New research developments in myelofibrosis

  41. 162

    Delivery of child-friendly antimalarial hits the 100 million mark

  42. 163

    Treating India's Leprosy patients

  43. 164

    Treating leprosy, caring for patients

  44. 165

    "SMS for Life" is expanding

  45. 166

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  46. 167

    Critical issues facing the advanced breast cancer patient community

  47. 168

    Advice to newly diagnosed advanced breast cancer patients

  48. 169

    Insight into the advanced breast cancer patient journey

  49. 170

    Pioneering an innovative social business model to fight malaria

  50. 171

    New media: drivers of democratization and development?

  51. 172

    What is it like living with myelofibrosis (MF)?

  52. 173

    What is the prognosis of myelofibrosis (MF)?

  53. 174

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  54. 175

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  55. 176

    What is myelofibrosis (MF)?

  56. 177

    How is the patient journey for advanced breast cancer patients different?

  57. 178

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  58. 179

    What is progression free survival and why is it important?

  59. 180

    What guidance do you give patients and family coping with advanced breast cancer?

  60. 181

    What insights can you share with newly diagnosed patients?

  61. 182

    Molecular pathways:The future of research at NIBR

  62. 183

    The importance of organ donation

  63. 184

    Novartis BioCamp 2011 (German)

  64. 185

    Novartis BioCamp 2011 (French)

  65. 186

    How is research in advanced breast cancer evolving?

  66. 187

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  67. 188

    What can a patient expect if diagnosed with advanced breast cancer?

  68. 189

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  69. 190

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  70. 191

    How does the advanced breast cancer treatment journey differ for patients?

  71. 192

    Novartis Be Healthy

  72. 193

    Novartis BioCamp 2011

  73. 194

    A sign from above

  74. 195

    Charlie

  75. 196

    Happy endings

  76. 197

    Herpes #1

  77. 198

    Herpes it's black and white

  78. 199

    Herpes the Ninja virus

  79. 200

    Magical elves with HSV

  80. 201

    Open happiness

  81. 202

    Play it smart

  82. 203

    Quarantine

  83. 204

    Strings

  84. 205

    Ah! Real herpes

  85. 206

    Down there

  86. 207

    Don't let herpes put you off

  87. 208

    Arogya Parivar: A social business model to improve health in rural India

  88. 209

    Living with multiple myeloma

  89. 210

    What are the symptoms of myelofibrosis (MF)?

  90. 211

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  91. 212

    Animals & Research: Think how far we've come

  92. 213

    SMS for Life

  93. 214

    Alcon: helping the world see better

  94. 215

    Cataract Surgery

  95. 216

    Life with cataracts

  96. 217

    CEO Joseph Jimenez on Alcon merger

  97. 218

    Extraordinary dogs: enriching life for disabled veterans

  98. 219

    Improving access to healthcare: too big to solve alone

  99. 220

    Drug discovery and development process

Loading...
Working...
to add this to Watch Later

Add to